168 filings
Page 6 of 9
6-K
kcfip6yw
2 Jun 21
Current report (foreign)
6:30am
6-K
v01rfdgq 55wuhh
26 May 21
CENTOGENE Announces the Nomination of Rene Just as Chief Financial Officer
6:30am
6-K
qyvg92
18 May 21
CENTOGENE Appoints Michael Motz as Chief Commercial Officer, Pharmaceuticals
6:54am
IRAN
kr9c9k8mwa58xco9tmd2
15 Apr 21
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
9:05am
6-K
saxdaathrnavti2k
15 Apr 21
CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results
6:01am
6-K
kqw34u qkvaj
8 Apr 21
Current report (foreign)
6:00am
6-K
485c sw54n
18 Dec 20
CENTOGENE Announces Voting Results of Extraordinary General Meeting
9:15am
6-K
u0xnk 64at24o9
16 Dec 20
CENTOGENE Reports Third-Quarter 2020 Financial Results and Increases Full Year Guidance
6:44am
6-K
xf1ffy gutk2vpr
9 Dec 20
Current report (foreign)
6:08am
6-K
k2u fjlo93g
8 Dec 20
Current report (foreign)
6:02am
6-K
kyzmazfxna87ltieg09z
3 Dec 20
Current report (foreign)
4:43pm
6-K
abdbnws3k5jp b9a5
25 Nov 20
CENTOGENE Expands Partnership with PTC Therapeutics to Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
12:19pm
6-K
ps8n 3u8klv6xuznb1x
13 Nov 20
CENTOGENE Announces Nomination of Jonathan Sheldon to Supervisory Board
12:15pm
6-K
qjkn549u3hrw9nf
9 Nov 20
Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing
11:13am
6-K
6b5mv7u
20 Oct 20
Current report (foreign)
8:15am
6-K
5rjvlen47dp
20 Oct 20
CENTOGENE Announces Leadership Transition
6:01am
6-K
ibf2u rcl7nf
15 Oct 20
Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands
6:02am
6-K
mxlspt89it fl
23 Sep 20
CENTOGENE Reports First Half 2020 Financial Results
11:43am
6-K
tc3sthz
16 Sep 20
Current report (foreign)
8:17am